Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors
Malcolm H. Squires, Patrick J. Worth, Bhavana Konda, et al.
Pancreas (2020) Vol. 49, Iss. 3, pp. 355-360
Closed Access | Times Cited: 42

Showing 1-25 of 42 citing articles:

The efficacy of streptozotocin in managing pancreatic neuroendocrine neoplasms – A systematic review
Giulia Arrivi, Nicola Fazio, Salvatore Tafuto, et al.
Cancer Treatment Reviews (2025), pp. 102899-102899
Open Access | Times Cited: 1
Neuroendocrine liver metastases: a contemporary review of treatment strategies
Jordan M. Cloyd, Aslam Ejaz, Bhavana Konda, et al.
HepatoBiliary Surgery and Nutrition (2020) Vol. 9, Iss. 4, pp. 440-451
Open Access | Times Cited: 51
Development and validation of CT-based radiomics deep learning signatures to predict lymph node metastasis in non-functional pancreatic neuroendocrine tumors: a multicohort study
Wenchao Gu, Yingli Chen, Hai-Bin Zhu, et al.
EClinicalMedicine (2023) Vol. 65, pp. 102269-102269
Open Access | Times Cited: 19
Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor
Yu Zhou, Si‐Yang Maggie Liu, Chao Liu, et al.
International Journal of Biological Sciences (2021) Vol. 17, Iss. 14, pp. 3760-3775
Open Access | Times Cited: 35
Surgical Management of Pancreatic Neuroendocrine Tumors
Megan L. Sulciner, Thomas E. Clancy
Cancers (2023) Vol. 15, Iss. 7, pp. 2006-2006
Open Access | Times Cited: 16
The feasibility and outcomes of metabolic and bariatric surgery prior to neoplastic therapy
Chetan Parmar, Kamal Abi Mosleh, Pauline Aeschbacher, et al.
Surgery for Obesity and Related Diseases (2024) Vol. 20, Iss. 8, pp. 717-728
Closed Access | Times Cited: 5
A Single-center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors
Stefano Partelli, Francesca Muffatti, Valentina Andreasi, et al.
Annals of Surgery (2022) Vol. 276, Iss. 5, pp. 921-928
Closed Access | Times Cited: 20
Surgical management of pancreatic neuroendocrine liver metastases
Jordan M. Cloyd, Jason T. Wiseman, Timothy M. Pawlik
Journal of Gastrointestinal Oncology (2020) Vol. 11, Iss. 3, pp. 590-600
Open Access | Times Cited: 29
Chemotherapy in Neuroendocrine Tumors
Satya Das, Taymeyah Al‐Toubah, Jonathan Strosberg
Cancers (2021) Vol. 13, Iss. 19, pp. 4872-4872
Open Access | Times Cited: 24
Capecitabine and Temozolomide (CAPTEM) in Advanced Neuroendocrine Neoplasms (NENs): A Systematic Review and Pooled Analysis
Giulia Arrivi, Monica Verrico, Michela Roberto, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 3507-3523
Open Access | Times Cited: 17
Overview of the histopathological and immunohistochemical characteristics of neuroendocrine neoplasms
Sonia L. El-Sharkawy, Manal Badawi, Wafaa E. Abdelaal, et al.
Bulletin of the National Research Centre/Bulletin of the National Research Center (2025) Vol. 49, Iss. 1
Open Access
The Landmark Series: Surgical Management of Functioning and Non-Functioning Pancreatic Neuroendocrine Tumors
Joseph Tobias, Callisia N. Clarke, Alexandra Gangi, et al.
Annals of Surgical Oncology (2025)
Open Access
The Landmark Series: Pancreatic Neuroendocrine Tumors
Jordan M. Cloyd, George A. Poultsides
Annals of Surgical Oncology (2020) Vol. 28, Iss. 2, pp. 1039-1049
Closed Access | Times Cited: 25
Induction therapy with 177Lu-DOTATATE procures long-term survival in locally advanced or oligometastatic pancreatic neuroendocrine neoplasm patients
Noémie S. Minczeles, Casper H.J. van Eijck, Marjon J. van Gils, et al.
European Journal of Nuclear Medicine and Molecular Imaging (2022) Vol. 49, Iss. 9, pp. 3203-3214
Open Access | Times Cited: 15
Prognostic factors after resection of locally advanced non-functional pancreatic neuroendocrine neoplasm: an analysis from the German Cancer Registry Group of the Society of German Tumor Centers
Thaer S. A. Abdalla, Monika Klinkhammer‐Schalke, Sylke Ruth Zeißig, et al.
Journal of Cancer Research and Clinical Oncology (2023) Vol. 149, Iss. 11, pp. 8535-8543
Open Access | Times Cited: 6
Surgery after sunitinib administration to improve survival of patients with advanced pancreatic neuroendocrine neoplasms
Yoshiki Murase, Atsushi Kudo, Keiichi Akahoshi, et al.
Annals of Gastroenterological Surgery (2021) Vol. 5, Iss. 5, pp. 692-700
Open Access | Times Cited: 11
Radioligand therapy (RLT) as neoadjuvant treatment for inoperable pancreatic neuroendocrine tumors: a literature review
Luca Urso, Alberto Nieri, Ilaria Rambaldi, et al.
Endocrine (2022) Vol. 78, Iss. 2, pp. 255-261
Open Access | Times Cited: 8
Advances in Management of Nonfunctional Pancreas Neuroendocrine Tumors
Alexandra W. Acher, Julie Hallet
Surgical Clinics of North America (2024) Vol. 104, Iss. 5, pp. 1095-1111
Closed Access | Times Cited: 1
Efficacy and safety of neoadjuvant therapy in gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis
Yu Yan, Danzhu Wu, Weizhen Wang, et al.
Journal of Cancer Research and Therapeutics (2024) Vol. 20, Iss. 2, pp. 633-641
Open Access | Times Cited: 1
National practice patterns in the use of endoscopic ultrasound biopsy for resectable Pancreatic Neuroendocrine Tumors: Insights into the role of DOTATATE PET/CT in diagnosis
Megan Casey, Audrey Brown, Fernanda Romero‐Hernández, et al.
The American Journal of Surgery (2024) Vol. 235, pp. 115779-115779
Open Access | Times Cited: 1
Development of an Artificial Intelligence Based Model to Predict Early Recurrence of Neuroendocrine Liver Metastasis Following Resection
Abdullah Altaf, Muhammad Musaab Munir, Yutaka Endo, et al.
Journal of Gastrointestinal Surgery (2024) Vol. 28, Iss. 11, pp. 1828-1837
Closed Access | Times Cited: 1
Neoadjuvant therapy with peptide receptor radionuclide therapy for pancreatic neuroendocrine tumours
Julie Hallet, Kjetil Søreide
British journal of surgery (2024) Vol. 111, Iss. 9
Open Access | Times Cited: 1
Pancreatic Neuroendocrine Neoplasms: Classification and Novel Role of Endoscopic Ultrasound in Diagnosis and Treatment Personalization
Matteo Tacelli, Stefano Partelli, Massimo Falconi, et al.
United European Gastroenterology Journal (2024)
Open Access | Times Cited: 1
Predicting Novel Drug Candidates for Pancreatic Neuroendocrine Tumors via Gene Signature Comparison and Connectivity Mapping
Yao Xiao, Gang Xu, Jordan M. Cloyd, et al.
Journal of Gastrointestinal Surgery (2022) Vol. 26, Iss. 8, pp. 1670-1678
Closed Access | Times Cited: 6
Similar Outcomes in Minimally Invasive versus Open Management of Primary Pancreatic Neuroendocrine Tumors: A Regional, Multi-Institutional Collaborative Analysis
Thomas L. Sutton, Rodney F. Pommier, Skye C. Mayo, et al.
Cancers (2022) Vol. 14, Iss. 6, pp. 1387-1387
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top